December 2, 2009
BioLife Solutions gets Japanese patent for biopreservation (PharmaBiz)
Hi there, more on baby cord blood research are described here.
Cord blood research offers hope (The Minnesota Daily)
By: Jerimiah Oetting Recent findings at the University of Minnesota may give new hope to patients battling leukemia, but donating to the cause is easier said than done. In the November issue of Blood, Dr. John Wagner and Dr. Michael Verneris from the University?s Masonic Cancer Center presented findings indicating that patients treated with two units of umbilical cord blood were less likely to . (Read More)
New Report: Advances in the Stem Cell Industry: The Future Impact of Innovation (PR Newswire via Yahoo! Finance)
Global stem cell market sales reached $410 million in 2008, and will grow to $2.68 billion by 2012 according to a new report on http://www.companiesandmarkets.com. (Read More)
China Cord Blood Corporation Announces Listing on NYSE and Pricing of Secondary Public Offering (PR Newswire via Yahoo! Finance)
China Cord Blood Corporation today is pleased to announce the successful listing of its ordinary shares on NYSE's main board and the completion of its secondary public offering. The Company's ordinary shares are expected to begin trading on the New York Stock Exchange on November 19, 2009 under the ticker symbol "CO." (Read More)
Apollo Hospitals in MoU with StemCyte (The Hindu)
NEW DELHI: Private healthcare chain, Apollo Hospitals, has signed a memorandum of understanding with US-based life sciences company StemCyte Inc for setting up cord blood bank facility in Ahmedabad. (Read More)
Tags: umbilical cord blood, cord stem cell








